University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Tobramycin nebulised#3.7

NHS England Commissioned for Cystic Fibrosis only, new patients

Status: Red Tocilizumab (Tyenne® Roactemra®)

Hospital use only

Status: Green Tolterodine M/R capsules

High relative cost. Second line.

Status: Amber Tolvaptan (Jinarc®)

Tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease

Status: Red Tolvaptan (Samsca®)

Consultant advice only. Tolvaptan (Samsca) for the treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Status: Amber Topiramate tablets

Prophylaxis of migraine. Specialist recommendation.

Status: Red Topotecan capsules

For hospital use only

Status: Green Tramadol capsules

Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties.

Status: Green Tramadol soluble tablets

Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties.

Status: Amber Tranexamic acid 5% mouthwash

Palliative use only

Building healthier lives
Back to top